Literature DB >> 10575027

Conservation of expression of neuropeptide Y5 receptor between human and rat hypothalamus and limbic regions suggests an integral role in central neuroendocrine control.

K A Nichol1, A Morey, M H Couzens, J Shine, H Herzog, A M Cunningham.   

Abstract

Neuropeptide Y receptors belong to the G-protein-coupled receptor superfamily and mediate a wide variety of physiological functions, including blood pressure regulation, hormone release, appetite control, seizure propensity, cognition, and emotion. The recent description of a new neuropeptide Y receptor, Y5, expressed in hypothalamic nuclei in rat brain, raised the possibility that Y5 was the receptor mediating the feeding and appetite-related functions of neuropeptide Y. This was supported by subsequent data showing a downregulation of this "feeding" receptor in the brain of the obese Zucker rat (Widdowson, 1997). We have performed a detailed analysis of Y5 expression in rat brain using in situ hybridization histochemistry with digoxygenin-labeled riboprobes and compared this to expression of Y5 in human brain regions. mRNA for the human Y5 receptor was highly expressed in human hypothalamic and thalamic nuclei. In particular, the arcuate and paraventricular nuclei of the hypothalamus, midline thalamic nuclei, and amygdala showed very high levels of expression with high levels in hippocampus. The striking conservation of expression of the rat and human Y5 receptors in relevant hypothalamic and other nuclei implies sharing of a major neuroendocrine functional role by this receptor.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10575027      PMCID: PMC6782429     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  45 in total

1.  Non-radioactive labeling and detection of nucleic acids. II. Optimization of the digoxigenin system.

Authors:  H J Höltke; R Seibl; J Burg; K Mühlegger; C Kessler
Journal:  Biol Chem Hoppe Seyler       Date:  1990-10

2.  A high concentration of NPY (Y1)-receptor mRNA-expressing cells in the rat arcuate nucleus.

Authors:  J D Mikkelsen; P J Larsen
Journal:  Neurosci Lett       Date:  1992-12-14       Impact factor: 3.046

Review 3.  Y-receptor subtypes--how many more?

Authors:  A G Blomqvist; H Herzog
Journal:  Trends Neurosci       Date:  1997-07       Impact factor: 13.837

4.  NPY Y1 receptor like immunoreactivity exists in a subpopulation of beta-endorphin immunoreactive nerve cells in the arcuate nucleus: a double immunolabelling analysis in the rat.

Authors:  K Fuxe; B Tinner; L Caberlotto; B Bunnemann; L F Agnati
Journal:  Neurosci Lett       Date:  1997-03-28       Impact factor: 3.046

Review 5.  Neuropeptide Y family of hormones: receptor subtypes and antagonists.

Authors:  A A Balasubramaniam
Journal:  Peptides       Date:  1997       Impact factor: 3.750

6.  Coexpression of leptin receptor and preproneuropeptide Y mRNA in arcuate nucleus of mouse hypothalamus.

Authors:  J G Mercer; N Hoggard; L M Williams; C B Lawrence; L T Hannah; P J Morgan; P Trayhurn
Journal:  J Neuroendocrinol       Date:  1996-10       Impact factor: 3.627

7.  Neuropeptide Y projection from arcuate nucleus to parvocellular division of paraventricular nucleus: specific relation to the ingestion of carbohydrate.

Authors:  M Jhanwar-Uniyal; B Beck; Y S Jhanwar; C Burlet; S F Leibowitz
Journal:  Brain Res       Date:  1993-12-17       Impact factor: 3.252

8.  Role of the Y5 neuropeptide Y receptor in feeding and obesity.

Authors:  D J Marsh; G Hollopeter; K E Kafer; R D Palmiter
Journal:  Nat Med       Date:  1998-06       Impact factor: 53.440

9.  Localization of neuropeptide Y Y1 receptors in the rat nervous system with special reference to somatic receptors on small dorsal root ganglion neurons.

Authors:  X Zhang; L Bao; Z Q Xu; J Kopp; U Arvidsson; R Elde; T Hökfelt
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

10.  Regional distribution of putative NPY Y1 receptors and neurons expressing Y1 mRNA in forebrain areas of the rat central nervous system.

Authors:  P J Larsen; S P Sheikh; C R Jakobsen; T W Schwartz; J D Mikkelsen
Journal:  Eur J Neurosci       Date:  1993-12-01       Impact factor: 3.386

View more
  7 in total

Review 1.  Hypothalamic regulatory pathways and potential obesity treatment targets.

Authors:  Erin E Jobst; Pablo J Enriori; Puspha Sinnayah; Michael A Cowley
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

2.  Macroglossia associated with brainstem injury.

Authors:  Ifeanyi Iwuchukwu; Agnieszka Ardelt; Wilson Cueva; Rwoof Reshi; Fernando Goldenberg; Jeffrey Frank
Journal:  Neurocrit Care       Date:  2014-02       Impact factor: 3.210

3.  Distribution of NPY Y5-like immunoreactivity in the rat brain.

Authors:  S Michelle Morin; Donald R Gehlert
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

Review 4.  PET Imaging of the Neuropeptide Y System: A Systematic Review.

Authors:  Inês C F Fonseca; Miguel Castelo-Branco; Cláudia Cavadas; Antero J Abrunhosa
Journal:  Molecules       Date:  2022-06-09       Impact factor: 4.927

5.  Neuropeptide Y receptor gene expression in the primate amygdala predicts anxious temperament and brain metabolism.

Authors:  Patrick H Roseboom; Steven A Nanda; Andrew S Fox; Jonathan A Oler; Alexander J Shackman; Steven E Shelton; Richard J Davidson; Ned H Kalin
Journal:  Biol Psychiatry       Date:  2013-11-15       Impact factor: 13.382

6.  Injections of muscimol into the paraventricular thalamic nucleus, but not mediodorsal thalamic nuclei, induce feeding in rats.

Authors:  Thomas R Stratford; David Wirtshafter
Journal:  Brain Res       Date:  2012-10-27       Impact factor: 3.252

Review 7.  G protein-coupled receptors in the hypothalamic paraventricular and supraoptic nuclei--serpentine gateways to neuroendocrine homeostasis.

Authors:  Georgina G J Hazell; Charles C Hindmarch; George R Pope; James A Roper; Stafford L Lightman; David Murphy; Anne-Marie O'Carroll; Stephen J Lolait
Journal:  Front Neuroendocrinol       Date:  2011-07-23       Impact factor: 8.606

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.